维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="ROSEN DH"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	The role of existential meaning as a buffer against stress显示文摘	Mascaro N Rosen DH	2006	J Human Psychol2006，46，2：	1
2	Daily iron supplementation is more effective than twice weekly iron supplementation for the treatment of childhood anemia in Western Kenya显示文摘	DESAI MR DHAR R ROSEN DH	2004	J Nutr2004，134，5：	1
3	Zoledronic acid issuperior to pamidronate for the treatment of bone metastases inbreast carcinoma patients with at least one osteolytic lesion 显示文摘	Rosen LS Gordon DH Dugan W Jr	2004	Cancer2004，100，1：	1
4	Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion显示文摘	Gordon DH Dugan W Jr at al	2004	Cancer2004，100，1：	1
5	The role of existential meaning as a buffer against stress显示文摘	MASCARO N ROSEN DH	2006	Journal of Humanistic Psychology2006，46，2：	1
6	Endoscopic surgical management of sphenoid sinus disease显示文摘	Rosen FS Sinha UK Rice DH	1999	Laryngoscope1999，109，：	1
7	Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinema patients with at least one osteolytic lesion 显示文摘	Rosen LS Gordon DH Dugan W Jr	2004	Cancer2004，100，1：	1
8	Use of intra-aortie balloon pump counterpulsation for refractory symptomatic vasospasm显示文摘	Sekhar LN Duong DH	2000	Acts Neurochir2000，142，：	1
9	Gene trap disruption of the mouse heparan sulfate 6-0-endosulfatase gene, Sult2 显示文摘	Lum DH Tan J Rosen SD	2007	Mol Cell Biol2007，27，2：	1
10	Zoledrenic acid is superior to pamidrenate for the treatment of bone metastases in breast carcinoma patients with at least osteolytic lesion 显示文摘	Rosen LS Gordon DH Dugan W	2004	Cancer2004，100，1：	1
11	Zoledronic acid is su-perior to pamidronate for the treatment of bone metastases inbreast carcinoma patients with at least one osteolytic lesion显示文摘	Rosen LS Gordon DH Dugan WJ	2004	Cancer2004，100，1：	1
12	Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one asteolytic lesion显示文摘	Rosen LS Gordon DH Dugan WJ	2004	Cancer2004，100，1：	1
13	Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion显示文摘	Rosen LS Gordon DH Dugan WJ		0，，01：	1
14	Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion显示文摘	Rosen LS Gordon DH Dugan W Jr	2004	Cancer2004，100，1：	1
15	Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion显示文摘	Rosen LS Gordon DH Dugan WJ	2004	Cancer2004，100，1：	1
16	Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion 显示文摘	Rosen LS Gordon DH Dugan W	2004	Cancer2004，100，1：	1
17	Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcino- ma patients with at least one osteolytic lesion显示文摘	Rosen LS Gordon DH Dugan W	2004	Cancer2004，100，1：	1
18	Zoledronic acid is superior to pamidronate for the treatment of hone metastases in breast carcinoma patients with at least one osteolytie lesion 显示文摘	Rosen LS Gordon DH Dugan W Jr	2004	Cancer2004，100，1：	1
19	Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcino- ma patients with at least one osteolytic lesion显示文摘	Rosen LS Gordon DH Dugan WJ	2004	Cancer2004，100，1：	1
20	Health and nutritional status of orphans< 6 years old cared for by relatives in western Kenya显示文摘	Lindblade KA Odhiambo F Rosen DH	2003	Trop Med Int Health2003，8，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示